14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 172 days ( 4.29 % )
Last Price 46.06€ 0 %
High/ Low 46.06€ - 46.06€ 0%
Chg 7 Days N/A $46.06 46.06€
Chg 30 Days N/A $46.06 46.06€
Chg 12 mos -9.11 % $50.67 46.06€
Trend - 3 mos N/A Width: 0.00000000 %
Trend - 12 mos -1.64 % Width: 22.55 %
Pred. range - 3 mos 46.06€ - 46.06€ 0 % - 0 %
Pred. range - 12 mos 40.46€ - 49.58€ -12.15 % - 7.66 %
Short MA avg 3 mos Sell Nov 30, -1 - N/A days
Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short/Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short MA avg 12 mos Buy Jan 19, 2022 - 149 days
Long MA avg 12 mos Buy May 25, 2022 - 61 days
Short/Long MA avg 12 mos Buy May 25, 2022 - 61 days
Pivot Short Buy Aug 16, 2022 - 2 days
Bollinger Sell Nov 30, -1 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About Galapagos NV

Galapagos NV Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative colitis, small bowel CD, fistulizing CD, ankylosing spondylitis, psoriatic arthritis, and uveitis. The compan... GLPG.AS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT